Michael Brown, MD
Physical Medicine & Rehabilitation · Oklahoma City, OKNPI 1063444974
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Pfizer accounts for 67.7% of it on its own, with 6 other manufacturers making up the rest.
Across 35 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$420
- AbbVie$80
- Amneal Pharmaceuticals LLC$39
- ANI Pharmaceuticals, Inc.$28
- Vertex$26
- Coloplast$17
- plus $12 from 1 others
What the payments were for
- Food & beverage$621100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 26 | $420 |
| AbbVie | 3 | $80 |
| Amneal Pharmaceuticals LLC | 2 | $39 |
| ANI Pharmaceuticals, Inc. | 1 | $28 |
| Vertex | 1 | $26 |
| Coloplast | 1 | $17 |
| Medtronic | 1 | $12 |
How this compares
$621 in reported general payments places this provider in the 85th percentile of 51 physical medicine & rehabilitation providers in Oklahoma.
See all physical medicine & rehabilitation providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 113 | $1,924 |
| Gabapentin | 71 | $1,482 |
| Tizanidine Hcl | 84 | $1,258 |
| Duloxetine Hcl | 42 | $720 |
| Pregabalin | 32 | $647 |
| Tramadol Hcl ErTramadol Hcl | 11 | $524 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 11 | $511 |
| Tramadol Hcl | 70 | $436 |
| Trazodone Hcl | 21 | $392 |
| Baclofen | 41 | $390 |
| Oxycodone Hcl | 18 | $389 |
| Methocarbamol | 30 | $207 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $153 |
| Meclizine Hcl | 12 | $131 |
| Meloxicam | 21 | $114 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Oklahoma City
- Jonathan StoneOklahoma City$2K
- Alan TranOklahoma City$2K
- Christopher BouvetteOklahoma City$772
- Kimberly BouvetteOklahoma City$613
- Albert BissonOklahoma City$543
- Gary SchickOklahoma City$357
- Christina BartonOklahoma City$319
- Michael SmithOklahoma City$180
- David TiptonOklahoma City$84
- Darryl RobinsonOklahoma City$76
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.